State Street Corporation 13D and 13G filings for Neurocrine Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-05 06:50 am Sale | 2024-12-31 | 13G | Neurocrine Biosciences, Inc. NBIX | STATE STREET CORP STT | 4,891,137 4.800% | -257,156 (-4.99%) | Filing |
| 2024-10-17 09:54 am Purchase | 2024-09-30 | 13G | Neurocrine Biosciences, Inc. NBIX | STATE STREET CORP STT | 5,148,293 5.100% | 5,148,293 (New Position) | Filing |